The global throat sprays market is expected to reach a valuation of USD 484.0 million in 2023. Sales of throat sprays are expected to gain traction at a 2.1% CAGR over the forecast period, with the market size reaching USD 598.3 million by 2033.
One of the primary causes of many respiratory diseases is believed to be rising levels of air pollution and the spread of infections in urban areas. Particulate matter exposure can irritate the throat and induce soreness, which ranges from slight discomfort to severe discomfort.
Throat infections are more common now because of environmental changes, pollution, and air contamination. Manufacturers of throat sprays place a strong emphasis on new product introductions and ongoing innovation using organic ingredients and herbs.
Sales of throat sprays are expected to increase globally, as most throat sprays are over-the-counter (OTC) medicines that do not require a prescription from a doctor. Because customers are conditioned to treat common illnesses like colds, coughs, and sore throats at home rather than seeing a doctor, demand for throat sprays is likely to increase.
The market value for throat sprays was approximately 1.5% of the overall USD 32.0 billion of the global cold, cough & sore throat remedies market in 2021.
What are the Key Opportunities for Throat Sprays Manufacturers?
High Demand for Affordable Throat Sprays Across Emerging Economies is likely to Fuel Sales
Companies benefit from an increase in global market consolidation activities like mergers and acquisitions, partnerships, and collaboration. Offering well-known cough and cold remedies at affordable pricing is likely to aid in improving sales.
Significant growth prospects for the throat sprays market are anticipated across emerging economies thanks to increased promotional and awareness campaigns and improved healthcare access. These factors cumulatively present lucrative opportunities for growth in the throat sprays sector throughout the forecast period.
Which Factors are Restraining Demand for Throat Sprays?
One of the main barriers preventing the widespread use of specific drugs is medication errors or overdosing. The patient's health negatively be impacted by side effects from overdoses or drug resistance.
For example, sprays sold under different names, such as Hurricane, Topex, and Cetacaine, are frequently used to assist the placement of nasogastric tubes for small procedures. Such anesthetic sprays have the potential to lead to addiction and overdose.
The FDA has issued a warning that certain documented cases of methemoglobinemia have been linked to medication errors because of improper benzocaine spray usage (e.g., longer duration or more frequent sprays than recommended).
Medication errors have a negative impact on a patient's health and hinder the use of the product, which can limit sales in the market. Additionally, the availability of alternatives is likely to limit the use of throat sprays because they are more readily available and more reasonably priced than throat sprays.
| Attributes | Details |
|---|---|
| Throat Sprays Market CAGR (2023 to 2033) | 2.1% |
| Throat Sprays Market Size (2023) | USD 484 million |
| Throat Sprays Market Size (2033) | USD 598.3 million |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Sales of throat sprays are forecast to increase at a 2.1% CAGR over the assessment period, in comparison to the CAGR of 2.0% registered between 2018 to 2022, owing to the advent of the infections associated with the COVID-19 pandemic. Market valuation went up from USD 437.38 million in 2018 to USD 473.8 million in 2022.
Among the most prevalent illnesses in primary care are upper respiratory tract infections including laryngitis, pharyngitis, nasopharyngitis, and rhinitis. Symptoms include coughing, sore throat, nasal obstruction, and headache.
Even in the absence of treatment, acute sore throats are self-limiting and often go away in 3 to 7 days. However, the discomfort brought on by a sore throat can considerably affect daily activities and quality of life, and it continues to be one of the most frequent causes of primary care consultations.
With peak sales throughout the cold and flu season, sales of throat sprays are expected to gain traction. Ingredients in the formulation could be used to treat symptoms or stop the spread of a viral infection.
Throat sprays are a desirable delivery route for over-the-counter medications, such as sore throat remedies, due to the relatively low developmental barriers. Choosing a reliable and practical medication delivery system is vital to developing brand loyalty in the market.
In the European Union, oral/throat sprays are frequently endorsed as medical devices to prevent common colds. For example, the trypsin/glycerol mouth spray claims that it can shorten/reduce common cold symptoms, stop colds, and stop the host cell infection from the COVID-19 virus.
Topical delivery methods provide various benefits over systemic drug administration, including enhanced product bioavailability, decreased adverse and off-target effects, and greater patient convenience, which promotes compliance. For effective delivery of medications for pain relief, throat sprays are a preferred mode of administration to provide symptomatic relief to patients with common cold and associated infections of the throat.
| Country | Market Share (2023) |
|---|---|
| United States | 34.7% |
| Germany | 6.1% |
| Japan | 5.0% |
| Australia | 1.5% |
Increasing Demand for Sore Throat Sprays is likely to Boost Sales
The United States dominated the North America throat sprays industry in 2022, holding 90.1% of the market share. As per FMI, the trend is expected to continue over the forecast period owing to numerous awareness campaigns aimed at reducing infectious diseases as well as the existence of various key throat sprays and lozenge manufacturers in the country.
Growing Sales of Antiseptic Throat Sprays in Germany is likely to Fuel Growth
Demand in the Germany market is set to increase at a 2.9% CAGR over the assessment period. Rising prevalence of throat infections, owing to environmental factors such as cold weather conditions is spurring demand for throat sprays. With a high prevalence of throat infections in the pediatric population, manufacturers are launching throat sprays for kids for pain relief.
Consumers in China are Preferring Throat Spray for Cough
China held approximately 53.2% of the East Asia throat sprays market share in 2021, and sales are projected to increase at a 1.9% CAGR over the assessment period. Manufacturers in China are developing herbal nasal and throat spray from longan extract for infections such as COVID-19, which has increased the adoption of herbal formulations for throat sprays.
Demand for Anaesthetic Throat Sprays is likely to Gain Traction
Based on spray type, sales of anesthetic throat sprays is likely to increase at a 2.4% CAGR by 2033. Initially, it held 29.5% of the total market share in 2022. The spray contains a local anesthetic with rapid onset of action. It delivers the spray directly to the area of pain for targeted pain relief, quickly relieving discomfort associated with a sore throat.
Sales of Pumps and Dispensers is likely to Remain High
Pumps and dispensers hold a revenue share of around 66.3% in 2022 and are expected to display gradual growth over the forecast period. Growing concerns about the environmental impact of aerosols is expected to fuel sales in this segment. Thus, sustainable products are increasingly preferred over traditional sprays.
Demand for Throat Sprays in Hospital Pharmacies is likely to Increase
Hospital pharmacies accounted for the leading share 33.4% in 2022, and the trend is expected to continue over the forecast period. The prevalence of chronic and infectious disorders is on the rise, which continue pushing sales in this segment over the forecast period.
Battle of the Sprays: Competitors Vie for Dominance in the Throat Sprays Industry
Technology advancements, strategic partnerships, R&D spending, and research all contribute significantly to the market expansion for throat sprays. Instances of key developmental strategies by the industry players in the throat sprays market are:
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The projected revenue of the market by 2033 is USD 598.3 million.
The market CAGR for 2033 is projected to be 2.1%.
Vicks, Strepsils, and Chloraseptic. are the key market players.
The market is estimated to secure a valuation of USD 484 million in 2023.
North America is growing fast due to the increasing prevalence of respiratory diseases.
| Expected Market Value (2023) | USD 37,258.5 million |
|---|---|
| Anticipated Forecast Value (2033) | USD 60,114.7 million |
| Projected Growth Rate (2023 to 2033) | CAGR 4.90% |
| Expected Market Value in 2023 | USD 2.08 billion |
|---|---|
| Expected Market Value in 2033 | USD 3.2 billion |
| Market CAGR (2023 to 2033) | 4.41% |
Explore Therapeutic Device Insights
View Reports
Throat Sprays Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
